Gmpd was the largest of Cardinal Health Inc’s 2 reported lines in fiscal 2026, at $12.72B — 53% of $24.05B.
| Operating and Reportable Segment | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical & Specialty Solutions | $188.81B | $210.02B | $204.64B | — | |||||||||||||
| Pharmaceutical | — | — | — | — | |||||||||||||
| Medical | — | — | — | — | |||||||||||||
| Gmpd | $12.22B | $12.38B | $12.64B | $12.72B | |||||||||||||
| Other Operating | $4.02B | $2.87B | $3.48B | $11.33B | |||||||||||||
| Corporate | — | — | — | — | |||||||||||||
| Total | $205.06B | $225.27B | $220.76B | $24.05B |
In fiscal 2026, which ended June 30, 2026, the 2 segments Cardinal Health Inc reported in this breakdown added up to $24.05B. That is less than the $254.34B in its breakdown by region, so these segments do not account for all of its revenue that year. Gmpd was the largest segment, at $12.72B or 52.9% of the total, followed by Other Operating ($11.33B, 47.1%).
Compared with fiscal 2025, Other Operating grew the fastest, rising 225.5% to $11.33B. Because segments were added or dropped between the two years, part of this reflects how Cardinal Health Inc regrouped its reporting.
The table also keeps 4 segments that Cardinal Health Inc no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2010 to 2026, as reported in Cardinal Health Inc's annual filings.
United States was the largest of Cardinal Health Inc’s 2 reported lines in fiscal 2026, at $252.64B — 99% of $254.34B.
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $203.44B | $225.23B | $220.99B | $252.64B | |||||||||||
| International | $1.62B | $1.68B | $1.67B | $1.71B | |||||||||||
| Total | $205.06B | $226.91B | $222.66B | $254.34B |
In fiscal 2026, which ended June 30, 2026, the 2 regions Cardinal Health Inc reported in this breakdown added up to $254.34B. That was up 14.2% from $222.66B in fiscal 2025. United States was the largest region, at $252.64B or 99.3% of the total, followed by International ($1.71B, 0.7%).
Over fiscal 2023 to 2026, revenue across these regions went from $205.06B to $254.34B, a compound annual growth rate of 7.4%. United States held a steady share of about 99.3%.
This breakdown covers every fiscal year from 2012 to 2026, as reported in Cardinal Health Inc's annual filings.
As Reported was the largest of Cardinal Health Inc’s 2 reported lines in fiscal 2024, at $54.91B — 100% of $54.87B.
| Revision of Prior Period | FY 2022 | FY 2022 | FY 2022 | FY 2023 | FY 2023 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| As Reported | $181.36B | $49.60B | $51.47B | $50.49B | $54.76B | $57.45B | $54.91B |
| Adjustment | -$38.00M | -$11.00M | -$1.00M | $11.00M | -$113.00M | -$3.00M | -$43.00M |
| Total | $181.33B | $49.59B | $51.47B | $50.50B | $54.65B | $57.44B | $54.87B |
In fiscal 2024, which ended March 31, 2024, the 2 revenue lines Cardinal Health Inc reported in this breakdown added up to $54.87B. That was down 4.5% from $57.44B in fiscal 2023. As Reported was the largest revenue line, at $54.91B or 100.1% of the total.
Over fiscal 2022 to 2024, revenue across these revenue lines went from $181.33B to $54.87B, a compound annual decline of 45.0%. As Reported held a steady share of about 100.1%.
Figures are shown as reported, so the total is net of Adjustment, which was -$43.00M in fiscal 2024. This breakdown covers 7 fiscal years between 2022 and 2024, as reported in Cardinal Health Inc's annual filings.
Cardinal Health Inc (CAH) breaks its revenue down by segment, region and revenue line. In fiscal 2026, its largest segment was Gmpd, with $12.72B or 52.9% of the total, followed by Other Operating at $11.33B (47.1%).
Gmpd was Cardinal Health Inc's largest segment in fiscal 2026, with $12.72B in revenue, 52.9% of the $24.05B reported across its 2 segments.
United States was Cardinal Health Inc's largest region in fiscal 2026, with $252.64B in revenue, 99.3% of the $254.34B reported across its 2 regions.
As Reported was Cardinal Health Inc's largest revenue line in fiscal 2024, with $54.91B in revenue, 100.1% of the $54.87B reported across its 2 revenue lines.
Every figure is taken from Cardinal Health Inc's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2010 to 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.